Equasens Société anonyme (EPA:EQS)

Market Cap	501.32M -29.3%
Revenue (ttm)	236.52M +9.1%
Net Income	39.33M +8.6%
EPS	2.62 +9.6%
Shares Out	15.03M
PE Ratio	12.75
Forward PE	10.67
Dividend	1.40 (4.27%)
Ex-Dividend Date	Jul 1, 2026

Volume	7,784
Open	32.80
Previous Close	32.75
Day's Range	32.80 - 33.75
52-Week Range	32.50 - 53.70
Beta	0.57
Analysts	Strong Buy
Price Target	55.68 (+66.96%)
Earnings Date	Sep 28, 2026

About Equasens Société anonyme

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1996
• Employees: 1,462
• Stock Exchange: Euronext Paris
• Ticker Symbol: EQS

Financial Performance

In 2025, Equasens Société anonyme's revenue was 236.52 million, an increase of 9.12% compared to the previous year's 216.75 million. Earnings were 39.33 million, an increase of 8.55%.

Analyst Summary

According to 4 analysts, the average rating for EQS stock is "Strong Buy." The 12-month stock price target is €55.68, which is an increase of 66.96% from the latest price.

Price Target

€55.68

(66.96% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error